ViiV expands licensing deal for its HIV drug in low-income countries
Once again, ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
Once again, ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
Though cases are falling in two of the region's high-burden countries, officials from the Africa Centres for Disease Control and ...
showcake / iStock More than one third of children younger than 5 years old in low- and middle-income countries (LMICs) ...
Although insulin makers have launched several initiatives to improve access in dozens of low- and middle-income countries, the medicines reached ...
New research suggests only a fraction of multidrug-resistant bacterial infections in low- and middle-income countries (LMICs) are being treated with ...
New research reveals why life expectancy gains have slowed across Europe—and how proactive policies in some countries helped them weather ...
unoL / iStock CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) yesterday announced an award of $3.3 million to Pittsburgh-based Peptilogics to ...
Credit: Pixabay/CC0 Public Domain The U.S. is failing to keep pace with dozens of countries around the world due to ...
Credit: Unsplash/CC0 Public Domain Since 1970, 37 countries have cut the probability of their citizens dying before they reach age ...
Time from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.